1 |
(r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide |
Pyrazole |
- |
- |
- |
058 [1] 58 💬 |
2 |
1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride |
Piperazine |
[6] D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 [1] 58 💬 |
3 |
[myk-461] |
- |
- |
- |
- |
058 [1] 58 💬 |
4 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
5 |
Adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [3] 13, 58, 65 💬 |
6 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
7 |
Alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [4] 13, 58, 279, 298 💬 |
8 |
Antiarrhythmic drugs |
- |
- |
- |
- |
058 [1] 58 💬 |
9 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
10 |
Behavioral: lifestyle |
- |
- |
- |
- |
058 [1] 58 💬 |
11 |
Bluefish |
Bluefish |
- |
- |
- |
058 [1] 58 💬 |
12 |
Bnp |
- |
- |
- |
- |
046 [2] 46, 58 💬 |
13 |
Bnp blood sample test |
- |
- |
- |
- |
058 [1] 58 💬 |
14 |
Candesartan |
Candesartan |
[1] D00522 D00522 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [2] 58, 67 💬 |
15 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
16 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 [1] 58 💬 |
17 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 [1] 58 💬 |
18 |
Ck-3773274 |
- |
- |
- |
- |
058 [1] 58 💬 |
19 |
Ck-3773274 (10 - 30 mg) |
- |
- |
- |
- |
058 [1] 58 💬 |
20 |
Ck-3773274 (5 - 15 mg) |
- |
- |
- |
- |
058 [1] 58 💬 |
21 |
Ck-3773274 - granules in capsule |
- |
- |
- |
- |
058 [1] 58 💬 |
22 |
Ck-3773274 - tablets |
- |
- |
- |
- |
058 [1] 58 💬 |
23 |
Ct-g20 |
- |
- |
- |
- |
058 [1] 58 💬 |
24 |
Cufence |
- |
- |
- |
- |
058 [1] 58 💬 |
25 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
26 |
Cyclosporine a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [10] 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
27 |
Device: insertable cardiac monitor |
Methamidophos |
- |
- |
- |
058 [1] 58 💬 |
28 |
Device: magnetic resonance imaging (mri) with gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 [1] 58 💬 |
29 |
Device: magnetic resonance imaging (mri) without gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 [1] 58 💬 |
30 |
Device: use of bioanalytical assay to monitor plasma levels of perhexiline |
Methamidophos |
[2] D05442 D05442, D08340 D08340 💬 |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway [45] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
31 |
Diagnostic test: air venous plethysmography |
- |
- |
- |
- |
058 [1] 58 💬 |
32 |
Diagnostic test: echocardiography |
- |
- |
- |
- |
058 [1] 58 💬 |
33 |
Diagnostic test: electrocardiogram |
- |
- |
- |
- |
058 [1] 58 💬 |
34 |
Diagnostic test: exercise stress transthoracic echocardiogram |
- |
- |
- |
- |
058 [1] 58 💬 |
35 |
Diagnostic test: holter ecg |
- |
- |
- |
- |
058 [1] 58 💬 |
36 |
Diagnostic test: phosphorous magnetic resonance spectroscopy |
Phosphorus |
- |
- |
- |
058 [1] 58 💬 |
37 |
Diagnostic test: upper member arterial doppler echography with analysis of fmd |
- |
- |
- |
- |
058 [1] 58 💬 |
38 |
Diltiazem |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 58, 86 💬 |
39 |
Diovan |
- |
- |
- |
- |
058 [1] 58 💬 |
40 |
Diovan 160 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
41 |
Diovan 40 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
42 |
Diovan 80 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
43 |
Dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [3] 57, 58, 215 💬 |
44 |
Echo and myocardial contrast echocardiography perfusion imaging |
- |
- |
- |
- |
058 [1] 58 💬 |
45 |
Eleclazine |
Eleclazine |
[1] D11155 D11155 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
058 [1] 58 💬 |
46 |
Endothelial function biomarkers |
- |
- |
- |
- |
058 [1] 58 💬 |
47 |
Entresto |
- |
- |
- |
- |
058 [1] 58 💬 |
48 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 [6] 13, 34, 46, 58, 65, 86 💬 |
49 |
Gradient |
- |
- |
- |
- |
058 [4] 58, 86, 149, 215 💬 |
50 |
Gs-6615 3 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
51 |
Gs-6615 3 mg pink |
- |
- |
- |
- |
058 [1] 58 💬 |
52 |
Gs-6615 3 mg white |
- |
- |
- |
- |
058 [1] 58 💬 |
53 |
Gs-6615 6 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
54 |
Gs-6615 6 mg white |
- |
- |
- |
- |
058 [1] 58 💬 |
55 |
Gutron 2,5mg |
- |
- |
- |
- |
058 [1] 58 💬 |
56 |
Gutron 5mg |
- |
- |
- |
- |
058 [1] 58 💬 |
57 |
Hyperpolarized 13c-pyruvate |
- |
- |
- |
- |
058 [1] 58 💬 |
58 |
Lcz696 |
- |
- |
- |
- |
058 [1] 58 💬 |
59 |
Lcz696 100 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
60 |
Lcz696 200 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
61 |
Lcz696 50 mg |
- |
- |
- |
- |
058 [1] 58 💬 |
62 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
63 |
Losartan bluefish 50 mg |
Bluefish |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
64 |
Mangafodipir |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
013 [2] 13, 58 💬 |
65 |
Mavacamten |
Mavacamten |
- |
- |
- |
058 [1] 58 💬 |
66 |
Mek162 |
- |
- |
- |
- |
058 [2] 58, 195 💬 |
67 |
Metoprolol |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [6] 17, 57, 58, 113, 193, 226 💬 |
68 |
Metoprolol succinate |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [4] 57, 58, 113, 193 💬 |
69 |
Midodrine |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [3] 6 , 17, 58 💬 |
70 |
Midodrine hydrochloride |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
71 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
72 |
Myk-461 |
- |
- |
- |
- |
058 [1] 58 💬 |
73 |
N-acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [10] 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
74 |
Nitrate |
Nitrate |
[1] D02313 D02313 💬 |
- |
- |
058 [3] 58, 113, 299 💬 |
75 |
Other: exercise echocardiography |
- |
- |
- |
- |
058 [1] 58 💬 |
76 |
Other: mangafodipir trisodium |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
058 [1] 58 💬 |
77 |
Other: walk distance test |
- |
- |
- |
- |
058 [1] 58 💬 |
78 |
Perhexiline |
Perhexiline |
[2] D05442 D05442, D08340 D08340 💬 |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway [45] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 [2] 58, 272 💬 |
79 |
Perxexiline |
- |
- |
- |
- |
058 [1] 58 💬 |
80 |
Pexsig |
- |
- |
- |
- |
058 [1] 58 💬 |
81 |
Phosphorous |
Phosphorus |
- |
- |
- |
058 [1] 58 💬 |
82 |
Piperazine |
Piperazine |
[6] D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 [1] 58 💬 |
83 |
Pirfenidone |
Pirfenidone |
[1] D01583 D01583 💬 |
CCL2 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [82] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
84 |
Procedure: 3d electrocardiographic mapping (ecm) |
- |
- |
- |
- |
058 [1] 58 💬 |
85 |
Procedure: b-lines se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
86 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
87 |
Procedure: diastolic function se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
88 |
Procedure: echocardiography (tee) |
- |
- |
- |
- |
058 [1] 58 💬 |
89 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
90 |
Procedure: left ventricular outflow tract gradient se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
91 |
Procedure: mitral regurgitation se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
92 |
Procedure: pulmonary hemodynamics se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
93 |
Procedure: rf catheter ablation |
- |
- |
- |
- |
058 [1] 58 💬 |
94 |
Procedure: trans-right ventricular alcohol septal ablation (trvasa) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
058 [1] 58 💬 |
95 |
Pyrazole |
Pyrazole |
- |
- |
- |
058 [1] 58 💬 |
96 |
Ranexa |
- |
- |
- |
- |
058 [1] 58 💬 |
97 |
Ranexa*60cpr 500mg r.p. |
- |
- |
- |
- |
058 [1] 58 💬 |
98 |
Ranexa*60cpr 750mg r.p. |
- |
- |
- |
- |
058 [1] 58 💬 |
99 |
Ranolazine |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
002 [6] 2 , 58, 86, 96, 113, 114 💬 |
100 |
Ranolazine 1000 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
101 |
Ranolazine 500 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
102 |
Ranolazine 750 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
103 |
Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
104 |
Regadenoson |
Regadenoson |
[1] D05711 D05711 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
058 [1] 58 💬 |
105 |
Sacubitril |
Sacubitril |
[1] D10225 D10225 💬 |
MME [1] MME 💬 |
Alzheimer disease [4] Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system |
058 [1] 58 💬 |
106 |
Sacubitril valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
107 |
Sacubitril/valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
108 |
Sodium nitrate |
Nitrate |
[1] D02313 D02313 💬 |
- |
- |
058 [2] 58, 113 💬 |
109 |
Spironolactone |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
110 |
Treatment bx1514m |
- |
- |
- |
- |
058 [1] 58 💬 |
111 |
Trientine |
Triethylenetetramine |
- |
- |
- |
058 [2] 58, 171 💬 |
112 |
Trientine dihydrochloride |
Triethylenetetramine |
- |
- |
- |
058 [2] 58, 171 💬 |
113 |
Triethylinetetramine dihydrochloride |
- |
- |
- |
- |
058 [1] 58 💬 |
114 |
Trimetazidine |
Trimetazidine |
[2] D01606 D01606, D08642 D08642 💬 |
- |
- |
058 [2] 58, 86 💬 |
115 |
Trimetazidine dihydrochloride |
Trimetazidine |
[2] D01606 D01606, D08642 D08642 💬 |
- |
- |
058 [1] 58 💬 |
116 |
Trimetazidine dihydrochloride 20mg |
Trimetazidine |
[2] D01606 D01606, D08642 D08642 💬 |
- |
- |
058 [1] 58 💬 |
117 |
Valsartan |
Valsartan |
[1] D00400 D00400 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [7] 57, 58, 66, 75, 218, 222, 224 💬 |
118 |
Vastarel |
- |
- |
- |
- |
058 [1] 58 💬 |
119 |
Vastarel 20mg film coated tablets |
- |
- |
- |
- |
058 [1] 58 💬 |